Javascript must be enabled to continue!
Tissue-specific expression and promoter analyses of the human tissue kallikrein gene in transgenic mice
View through CrossRef
The expression of the tissue kallikrein gene is tissue-specific and exhibits a complex pattern of transcriptional and post-translational regulation. Information concerning the mechanism of its tissue-specific expression has been limited owing to the lack of suitable cell lines for the expression study. We approached this problem by introducing human tissue kallikrein gene constructs into mouse embryos, creating transgenic lines carrying its coding sequence with varying lengths of the promoter region. One construct (PHK) contained 801 bp in the 5′-flanking region and two deletion constructs contained either 302 bp (D300) or 202 bp (D200) of the promoter region. The expression of human tissue kallikrein in these transgenic mice was monitored by Northern blot, reverse transcriptase–PCR followed by Southern blot, and radioimmunoassay. In all three lines, human tissue kallikrein was expressed predominantly in the pancreas and at lower levels in other tissues, including salivary gland, kidney and spleen. This pattern was similar to that of tissue kallikrein expression in human tissues. The D300 line has higher levels of transgene expression than the D200 and PHK lines. The results indicate that the 202 bp segment immediately upstream of the translation starting site is sufficient to direct a tissue-specific expression pattern of the human tissue kallikrein gene, and that regulatory elements might exist between -801 and -202.
Title: Tissue-specific expression and promoter analyses of the human tissue kallikrein gene in transgenic mice
Description:
The expression of the tissue kallikrein gene is tissue-specific and exhibits a complex pattern of transcriptional and post-translational regulation.
Information concerning the mechanism of its tissue-specific expression has been limited owing to the lack of suitable cell lines for the expression study.
We approached this problem by introducing human tissue kallikrein gene constructs into mouse embryos, creating transgenic lines carrying its coding sequence with varying lengths of the promoter region.
One construct (PHK) contained 801 bp in the 5′-flanking region and two deletion constructs contained either 302 bp (D300) or 202 bp (D200) of the promoter region.
The expression of human tissue kallikrein in these transgenic mice was monitored by Northern blot, reverse transcriptase–PCR followed by Southern blot, and radioimmunoassay.
In all three lines, human tissue kallikrein was expressed predominantly in the pancreas and at lower levels in other tissues, including salivary gland, kidney and spleen.
This pattern was similar to that of tissue kallikrein expression in human tissues.
The D300 line has higher levels of transgene expression than the D200 and PHK lines.
The results indicate that the 202 bp segment immediately upstream of the translation starting site is sufficient to direct a tissue-specific expression pattern of the human tissue kallikrein gene, and that regulatory elements might exist between -801 and -202.
Related Results
Functional Analysis of Human Tissue Kallikrein in Transgenic Mouse Models
Functional Analysis of Human Tissue Kallikrein in Transgenic Mouse Models
AbstractClinical studies show that an inverse correlation exists between blood pressure and urinary kallikrein levels. It has been postulated that the tissue kallikrein-kinin syste...
Human tissue kallikrein induces hypotension in transgenic mice.
Human tissue kallikrein induces hypotension in transgenic mice.
We investigated the role of the kallikrein-kinin system in blood pressure control by developing transgenic mice overexpressing human tissue kallikrein. Two lines of transgenic mice...
Expression and characterization of rat kallikrein-binding protein in Escherichia coli
Expression and characterization of rat kallikrein-binding protein in Escherichia coli
Rat kallikrein-binding protein is a novel serine-proteinase inhibitor that forms a covalent complex with tissue kallikrein. We have purified rat kallikrein-binding protein and clon...
Identification of a new tissue-kallikrein-binding protein
Identification of a new tissue-kallikrein-binding protein
We have identified a tissue-kallikrein-binding protein in human serum and in the serum-free culture media from human lung fibroblasts (WI-38) and rodent neuroblastoma X glioma hybr...
e0061 The modulation of dilated cardiomyopathy by Hepc1 in cTnTR141W transgenic mice
e0061 The modulation of dilated cardiomyopathy by Hepc1 in cTnTR141W transgenic mice
Objective
Iron regulatory hormone hepcidin is possible to be possibly involved in the physiological function of heart and pathogenesis of heart disease. The curre...
e0048 CYP2E1 increases oxidative stress and induces apoptosis of cardio myocytes in transgenic mice
e0048 CYP2E1 increases oxidative stress and induces apoptosis of cardio myocytes in transgenic mice
Objective
Cytochrome P450 2E1 (CYP2E1) is an effective generator of reactive oxygen species, such as the superoxide anion radical and hydrogen peroxide. The expre...
Kallikrein–kinin in stroke, cardiovascular and renal disease
Kallikrein–kinin in stroke, cardiovascular and renal disease
Tissue kallikrein, a serine proteinase, produces the potent vasodilator kinin peptide from kininogen substrate. The levels of tissue kallikrein are reduced in humans and animal mod...
Muscle Delivery of Human Kallikrein Gene Reduces Blood Pressure in Hypertensive Rats
Muscle Delivery of Human Kallikrein Gene Reduces Blood Pressure in Hypertensive Rats
AbstractWe recently found that transgenic mice expressing human tissue kallikrein develop sustained hypotension. The result suggests that a continuous supply of human tissue kallik...

